24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule [Focalin] — RxCUI 1101934
RxNorm drug concept · Semantic branded drug
RxCUI 1101934
Semantic branded drug · SBD
● Current RxNorm concept 16 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1101934
Official name24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule [Focalin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Focalin 35 MG Extended Release Oral Capsule; Focalin XR 35 MG 24HR Extended Release Oral Capsule; Focalin XR 35 MG 24 HR Extended Release Oral Capsule
FDA products mapped16
Package NDCs mapped22
Reported Medicaid activity (SDUD)152,285 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dexmethylphenidate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dexmethylphenidate is essentially the more active half of methylphenidate — think of it as a more refined version. Regular methylphenidate (like Ritalin) is a mix of two mirror-ima...
- What exactly is dexmethylphenidate and how is it different from regular methylphenidate (Ritalin)?
- Either way is fine — dexmethylphenidate can be taken with or without food. If you're taking the extended-release capsule and you can't swallow it whole, you can open it and sprinkl...
- Should I take this with food or on an empty stomach?
🕸️ Concept Web — How 24 HR dexmethylphenidate hydrochloride 35 MG Ext... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule [Focalin]
RxCUI 1101934 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dexmethylphenidate
352372IN -
Dexmethylphenidate hydrochloride
353105PIN
-
Dexmethylphenidate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Focalin
352654BN
-
Focalin
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dexmethylphenidate Extended Release Oral Capsule
577227SCDF -
Dexmethylphenidate hydrochloride Extended Release Oral Capsule
2649165SCDFP -
Dexmethylphenidate Oral Product
1157802SCDG -
Dexmethylphenidate Pill
1158298SCDG -
Dexmethylphenidate hydrochloride Oral Product
2662739SCDGP -
Dexmethylphenidate hydrochloride Pill
2659215SCDGP -
Dexmethylphenidate Extended Release Oral Capsule [Focalin]
583299SBDF -
Dexmethylphenidate hydrochloride Extended Release Oral Capsule [Focalin]
2657308SBDFP - +5 more in this family
-
Dexmethylphenidate Extended Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule
1101932SCD -
Dexmethylphenidate hydrochloride 35 MG
1101931SCDC -
Dexmethylphenidate hydrochloride 35 MG [Focalin]
1101933SBDC
-
24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
24 HR dexmethylphenidate hydrochloride 35 MG Extended Release Oral Capsule
SCD · 1101932 -
Dexmethylphenidate hydrochloride 35 MG
SCDC · 1101931 -
Dexmethylphenidate Extended Release Oral Capsule
SCDF · 577227 -
Dexmethylphenidate hydrochloride Extended Release Oral Capsule
SCDFP · 2649165 -
Dexmethylphenidate Oral Product
SCDG · 1157802 -
Dexmethylphenidate Pill
SCDG · 1158298 -
Dexmethylphenidate hydrochloride Oral Product
SCDGP · 2662739 -
Dexmethylphenidate hydrochloride Pill
SCDGP · 2659215
Brand-Name Concepts
-
Dexmethylphenidate hydrochloride 35 MG [Focalin]
SBDC · 1101933 -
Dexmethylphenidate Extended Release Oral Capsule [Focalin]
SBDF · 583299 -
Dexmethylphenidate hydrochloride Extended Release Oral Capsule [Focalin]
SBDFP · 2657308 -
Focalin Oral Product
SBDG · 1171880 -
Focalin Pill
SBDG · 1171881 -
Focalin
BN · 352654
📦 FDA Products & Package NDCs
16 products · 22 package NDCs
22 package NDCs map to RxCUI 1101934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0430-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0430-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 00078-0432-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0432-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 00078-0433-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0433-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 00078-0493-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0493-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 00078-0608-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0608-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 00078-0609-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0609-05) | Focalin XR | Novartis Pharmaceuticals Corporation | 2005-05-31 |
| 66758-0235-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-235-01) | Focalin XR | Sandoz Inc | 2025-01-15 |
| 66758-0235-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-235-31) | Focalin XR | Sandoz Inc | 2025-11-17 |
| 66758-0236-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-236-01) | Focalin XR | Sandoz Inc | 2025-02-15 |
| 66758-0236-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-236-31) | Focalin XR | Sandoz Inc | 2025-12-16 |
| 66758-0237-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-237-01) | Focalin XR | Sandoz Inc | 2024-10-04 |
| 66758-0237-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-237-31) | Focalin XR | Sandoz Inc | 2026-06-30 |
| 66758-0238-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-238-01) | Focalin XR | Sandoz Inc | 2024-10-04 |
| 66758-0238-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-238-31) | Focalin XR | Sandoz Inc | 2026-06-30 |
| 66758-0239-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-239-01) | Focalin XR | Sandoz Inc | 2025-02-01 |
| 66758-0239-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-239-31) | Focalin XR | Sandoz Inc | 2025-11-17 |
| 66758-0240-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-240-01) | Focalin XR | Sandoz Inc | 2025-06-01 |
| 66758-0240-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-240-31) | Focalin XR | Sandoz Inc | 2025-11-17 |
| 66758-0241-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-241-01) | Focalin XR | Sandoz Inc | 2025-10-15 |
| 66758-0241-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-241-31) | Focalin XR | Sandoz Inc | 2025-11-17 |
| 66758-0242-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-242-01) | Focalin XR | Sandoz Inc | 2024-11-15 |
| 66758-0242-31 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66758-242-31) | Focalin XR | Sandoz Inc | 2025-11-17 |
Observed labelers:
Sandoz Inc (16) ·
Novartis Pharmaceuticals Corporation (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.